Associate Director/Director, Medical Affairs – Publications (Fully Remote)

Braveheart Bio; United States; À distance; USD 140 000 - 210 000; Plein temps

Résumé du poste

Braveheart Bio is a clinical-stage biopharmaceutical company developing therapies for hypertrophic cardiomyopathy and other serious cardiovascular diseases. With a proven leadership team, strong financial foundation, and a late-stage asset, it offers mission-driven professionals a fast-paced and collaborative culture.

The Publications Lead will own the global publication strategy for BHB-1893, coordinate publications execution, and lead abstracts, posters and manuscripts for major meetings.

Qualifications

• Advanced degree with 5-8+ years in publications or medical communications.
• Deep knowledge of GPP, ICMJE, clinical trial design and publication platforms.

Responsabilités

• Own the global publication strategy for BHB-1893 across the evidence lifecycle.
• Serve as the central point of coordination for publications execution.
• Lead abstract, poster, and manuscript development for major cardiovascular meetings.
• Build publications infrastructure, SOPs, and oversee agency management.

Connaissances

Publications strategy

Medical communications

ICMJE knowledge

GPP knowledge

Clinical trials design

Formation

Advanced scientific degree

Outils

Publication platforms

Description du poste

• Own the global publication strategy for BHB-1893 across the evidence lifecycle.
• Serve as the central point of coordination for publications execution.

Key Responsibilities:

• Develop and manage the integrated strategic publication plan and congress disclosures.
• Lead abstract, poster, and manuscript development for major cardiovascular meetings.
• Build publications infrastructure, SOPs, and oversee agency management.

Qualifications:

• Advanced scientific degree plus 5-8+ years in publications or medical communications.
• Deep knowledge of GPP, ICMJE, clinical trial design, and publication platforms.

Braveheart Bio is a clinical-stage biopharmaceutical company developing therapies for hypertrophic cardiomyopathy and other serious cardiovascular diseases. With a proven leadership team, strong financial foundation, and a late-stage asset, it offers mission-driven professionals a fast-paced and collaborative culture.